Consultations in molecular diagnostics: Rapid one-step carrier detection assay of mucolipidosis IV mutations in the Ashkenazi Jewish population

Journal of Molecular Diagnostics

Volumn 8, Issue 2, 2006, Pages 282-287

  Hantash, Feras M ^a   Olson, Susan C ^a,b   Anderson, Ben ^a   Buller, Arlene ^a   Chen, Rebecca ^a   Crossly, Beryl ^a   Sun, Weimin ^a   Strom, Charles M ^a  

^a QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^b Biocept Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ALLELE; ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN CELL; INCIDENCE; JEW; MAJOR CLINICAL STUDY; MOLECULAR PROBE; MUCOLIPIDOSIS; MUCOLIPIDOSIS TYPE 4; MUTANT; NUCLEOTIDE SEQUENCE; PREDICTION; VALIDATION PROCESS; WILD TYPE; ETHNOLOGY; GENETICS; METHODOLOGY; MUTATION; TIME;

ALLELES; DNA MUTATIONAL ANALYSIS; GENETIC SCREENING; HETEROZYGOTE; HUMANS; JEWS; MUCOLIPIDOSES; MUTATION; TIME FACTORS;

EID: 33744534530     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2006.050026     Document Type: Article

References (11)

1. Bassi MT, Manzoni M, Monti E, Pizzo MT, Ballabio A, Borsani G: Cloning of the gene encoding a novel integral membrane protein, mucolipidin - and identification of the two major founder mutations causing mucolipidosis type IV. Am J Hum Genet 2000, 67:1110-1120
2. Bargal R, Avidan N, Olender T, Ben Asher E, Zeigler M, Raas-Rothschild A, Frumkin A, Ben-Yoseph O, Friedlender Y, Lancet D, Bach G: Mucolipidosis type IV: novel MCOLN1 mutations in Jewish and non-Jewish patients and the frequency of the disease in the Ashkenazi Jewish population. Hum Mutat 2001, 17:397-402
3. Bargal R, Avidan N, Ben-Asher E, Olender Z, Zeigler M, Frumkin A, Raas-Rothschild A, Glusman G, Lancet D, Bach G: Identification of the gene causing mucolipidosis type IV. Nat Genet 2000, 26:118-123
4. Wang ZH, Zeng B, Pastores GM, Raksadawan N, Ong E, Kolodny EH: Rapid detection of the two common mutations in Ashkenazi Jewish patients with mucolipidosis type IV. Genet Test 2001, 5:87-92
5. Edelmann L, Dong J, Desnick RJ, Kornreich R: Carrier screening for mucolipidosis type IV in the American Ashkenazi Jewish population. Am J Hum Genet 2002, 70:1023-1027
6. Altarescu G, Sun M, Moore DF, Smith JA, Wiggs EA, Solomon BI, Patronas NJ, Frei KP, Gupta S, Kaneski CR, Quarrell OW, Slaugenhaupt SA, Goldin E, Schiffmann R: The neurogenetics of mucolipidosis type IV. Neurology 2002, 59:306-313
7. Goldin E, Cooney A, Kaneski CR, Brady RO, Schiffmann R: Mucolipidosis IV consists of one complementation group. Proc Nati Acad Sci USA 1999, 96:8562-8566
8. Sun M, Goldin E, Stahl S, Falardeau JL, Kennedy JC, Acierno Jr JS, Bove C, Kaneski CR, Nagle J, Bromley MC, Colman M, Schiffmann R, Slaugenhaupt SA: Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. Hum Mol Genet 2000, 9:2471-2478
9. Bargal R, Goebel HH, Latta E, Bach G: Mucolipidosis IV: novel mutation and diverse ultrastructural spectrum in the skin. Neuropediatrics 2002, 33:199-202
10. Strom CM, Crossley B, Redman JB, Quan F, Buller A, McGinniss M, Sun W: Molecular screening for diseases frequent in Ashkenazi Jews: lessons learned from more than 100,000 tests performed in a commercial laboratory. Genet Medicine 2004, 6:145-152
11. Krafft AE, Lichy JH: Time-motion analysis of 6 cystic fibrosis mutation detection systems. Clin Chem 2005, 51:1116-1122